BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22530521)

  • 1. [Pharmacovigilance study of influenza A H1N1 vaccination during the 2009-2010 season in France].
    Montastruc JL;
    Bull Acad Natl Med; 2011 Jun; 195(6):1309-16; discussion 1316-7. PubMed ID: 22530521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance].
    Durrieu G; Caillet C; Lacroix I; Jacquet A; Faucher A; Ouaret S; Sommet A; Perault-Pochat MC; Kreft-Jaïs C; Castot A; Damase-Michel C; Montastruc JL;
    Therapie; 2011; 66(6):527-40. PubMed ID: 22186078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [First season of pandemic influenza A/H1N1].
    Weil-Olivier C
    Rev Prat; 2010 Dec; 60(10):1388-91, 1394-8. PubMed ID: 21425535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort.
    Schuurmans MM; Tini GM; Dalar L; Fretz G; Benden C; Boehler A
    J Heart Lung Transplant; 2011 Jun; 30(6):685-90. PubMed ID: 21444211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
    Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL;
    Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two doses of pandemic influenza A(H1N1) vaccine: tolerability in healthy young children in the Netherlands.
    van't Klooster TM; Kemmeren JM; de Melker HE; Vermeer-de Bondt PE; van der Maas NA
    Hum Vaccin; 2011 Oct; 7(10):1048-54. PubMed ID: 21957494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
    Kurz X; Domergue F; Slattery J; Segec A; Szmigiel A; Hidalgo-Simon A
    Vaccine; 2011 Jun; 29(26):4378-87. PubMed ID: 21501644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High coverage and safety of influenza A (H1N1) 2009 monovalent vaccination among health care personnel in Thailand.
    Kiertiburanakul S; Malathum K; Watcharananan SP; Bunupuradah P; Piebpien P; Rujiraviroj U; Likitsinsipon W; Apivanich S; Kehachindawat P; Burakitcharoen R; Leelaudomlipi S; Wananukul W
    Am J Infect Control; 2011 Aug; 39(6):525-8. PubMed ID: 21612842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-adjuvanted 2009 influenza A (H1N1)v vaccine in pregnant women: the results of a French prospective descriptive study.
    Omon E; Damase-Michel C; Hurault-Delarue C; Lacroix I; Montastruc JL; Oustric S; Escourrou B
    Vaccine; 2011 Dec; 29(52):9649-54. PubMed ID: 22036887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse events following pandemic influenza vaccine Pandemrix® reported in the French military forces--2009-2010.
    Mayet A; Ligier C; Gache K; Manet G; Nivoix P; Dia A; Haus-Cheymol R; Verret C; Duron S; Faure N; Piarroux M; De Laval F; Simon F; Decam C; Chaudet H; Meynard JB; Rapp C; Deparis X; Migliani R
    Vaccine; 2011 Mar; 29(14):2576-81. PubMed ID: 21296693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses.
    Grimaldi-Bensouda L; Alpérovitch A; Besson G; Vial C; Cuisset JM; Papeix C; Lyon-Caen O; Benichou J; Rossignol M;
    Am J Epidemiol; 2011 Aug; 174(3):326-35. PubMed ID: 21652600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
    Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
    Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
    Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
    J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in reported adverse events following seasonal influenza vaccination among the French armed forces, 2008-2009: possible role of stimulated reporting and background cases of influenza-like infection.
    Mayet A; Nivoix P; Haus-Cheymol R; De Laval F; Verret C; Duron S; Faure N; Piarroux M; Decam C; Chaudet H; Meynard JB; Deparis X; Migliani R
    Public Health; 2012 Jan; 126(1):70-6. PubMed ID: 22137096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active surveillance of adverse effects of Pandemrix vaccine to prevent influenza A(H1N1) in Cuba].
    Galindo Santana BM; Peláez Sánchez OR; Galindo Sardiña MA; Leon Villafuerte M; Concepción Díaz D; Estruch Rancaño CL; Martínez Sánchez R; Santín Peña M
    Rev Cubana Med Trop; 2011; 63(3):231-8. PubMed ID: 23444612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacovigilance monitoring of a cohort of pregnant women vaccinated against influenza A(H1N1) variant virus in the Nord-Pas de Calais region of northern France.
    Auffret M; Béné J; Gautier S; Moreau-Crépeaux S; Caron J
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):114-8. PubMed ID: 23810001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season.
    Weil-Olivier C; Lina B
    Vaccine; 2011 Sep; 29(40):7075-9. PubMed ID: 21777639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Events temporarily associated with anti-influenza A (H1N1) vaccination in Mexico.
    Vidal P; Reyna J; Saldaña P; Richardson VL
    Arch Med Res; 2011 Oct; 42(7):627-32. PubMed ID: 22036935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.